Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ali Keshavarz-Shokri is active.

Publication


Featured researches published by Ali Keshavarz-Shokri.


Archive | 2011

Pharmaceutical compositions and administrations thereof

Goor Fredrick F. Van; Rossitza Gueorguieva Alargova; Tim Edward Alcacio; Sneha G. Arekar; Steven C. Johnston; Irina Nikolaevna Kadiyala; Ali Keshavarz-Shokri; Mariusz Krawiec; Elaine Chungmin Lee; Ales Medek; Praveen Mudunuri; Mark Jeffrey Sullivan; Noreen Tasneem Zaman; Beili Zhang; Yuegang Zhang; Gregor Zlokarnik


Archive | 2011

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

Ali Keshavarz-Shokri; Beili Zhang; Mariusz Krawiec


Archive | 2008

Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

Ali Keshavarz-Shokri; Christopher Ryan Young


Archive | 2011

Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihyderoxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide

Ali Keshavarz-Shokri; Beili Zhang; Tim Edward Alcacio; Elaine Chungmin Lee; Yuegang Zhang; Mariusz Krawiec


Archive | 2013

SOLID FORMS OF (4-ISOPROPOXY-3-METHOXYPHENYL)(2'-METHYL-6'-(TRIFLUOROMETHYL)-3',4'-DIHYDRO-2'H-SPIRO[PIPERIDINE-4,1'-PYRROLO[1,2-A]PYRAZINE]-1-YL)METHANONE

Benjamin Joseph Littler; Ali Keshavarz-Shokri; Beili Zhang; Robert Michael Hughes


Archive | 2017

CRYSTALLINE FORMS OF C21H22CI2N 4O2.

Gary A Decrescenzo; Dean Welsch; Kathy Stavropoulos; Irina Nikolaevna Kadiyala; Ali Keshavarz-Shokri; Petinka Vlahova; Stephan X.M. Boerrigter; Alexander Aronov; Alexander N. Scangas; Benjamin Joseph Littler; Rossitza Gueorguieva Alargova


Archive | 2017

CRYSTALLINE FORMS OF C21H22Cl2N4O2

Gary Decrescenzo; Dean Welsch; Petinka Vlahova; Stephan M. Boerrigter X; Alexander Aronov; Ali Keshavarz-Shokri; Alexander N. Scangas; Kathy Stavropoulos; Benjamin Joseph Littler; Irina Nikolaevna Kadiyala; Rossitza Gueorguieva Alargova


Archive | 2017

SYNTHETIC INTERMEDIATE OF (R)-1(2,2 -DIFLUOROBENZO[D][1,3]DIOXOL-5YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2YL)-1H-INDOL-5YL)CYCLOPROPANECARBOXAMIDE

Ali Keshavarz-Shokri; Beili Zhang; Tim Edward Alcacio; Elaine Chungmin Lee; Yuegang Zhang; Mariusz Krawiec


Archive | 2016

CRYSTALLINE FORM OF (R)-1(2,2 -DIFLUOROBENZO[D][1,3]DIOXOL-5YL)-N-(1-(2,3-DIHYDEROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2YL)-1H-INDOL-5YL)CYCLOPROPANECARBOXAMIDE

Ali Keshavarz-Shokri; Beili Zhang; Tim Edward Alcacio; Elaine Chungmin Lee; Yuegang Zhang; Mariusz Krawiec


Archive | 2016

CRYSTALLINE FORMS OF C21H22CI2N4O2

Gary A Decrescenzo; Dean Welsch; Petinka Vlahova; Stephan X.M. Boerrigter; Alexander Aronov; Ali Keshavarz-Shokri; Alexander N. Scangas; Kathy Stavropoulos; Benjamin Joseph Littler; Irina Nikolaevna Kadiyala; Rossitza Gueorguieva Alargova

Collaboration


Dive into the Ali Keshavarz-Shokri's collaboration.

Top Co-Authors

Avatar

Beili Zhang

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ales Medek

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge